GALENEA CORP has a total of 20 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Australia, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are GLSYNTHESIS INC, VASTOX PLC and SPINIFEX PHARM PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | China | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | United States | 2 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Medical preparations | |
#5 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Gerber David J | 9 |
#2 | Levenson Jonathan M | 9 |
#3 | Cottrell Jeffrey R | 8 |
#4 | Ryan Timothy A | 7 |
#5 | Shacham Sharon | 6 |
#6 | Harriman Geraldine | 4 |
#7 | Noiman Silvia | 4 |
#8 | Cheruku Srinivasa Rao | 4 |
#9 | Wu Laurence | 4 |
#10 | Dhanoa Dale S | 4 |
Publication | Filing date | Title |
---|---|---|
EP2464227A1 | Compounds and methods of use thereof | |
WO2010123577A2 | Compositions and methods for evaluating cognitive deficits | |
KR20110073494A | Synaptic vesicle cycling assays and systems | |
EP2037925A1 | Combinations comprising 5ht6 modulators and cholinesterase inhibitors | |
CN101203500A | Substituted arylamine compounds and uses as 5-HT6 moderator thereof |